AI-Powered question lists could help blood cancer patients get more from doctor visits

NCT ID NCT07226934

Recruiting now Symptom relief Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an AI-generated personalized question prompt list (GPT-QPL) can help people with lymphoma or multiple myeloma ask more useful questions during their outpatient appointments. Researchers will create tailored question lists for 40 patients using ChatGPT, then measure changes in how confident patients feel communicating with their doctors and how satisfied they are with the information they receive. The goal is to see if this simple AI tool is feasible and helpful for improving patient-doctor communication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: GPT-QPL (AI-generated personalized question prompt list)
What this could lead to: If it works, this could give patients a simple tool to get more useful information from their doctors and feel more in control of their care.
What could go wrong: This is a very small, early feasibility study with only 40 participants, so results may not apply to everyone. The AI tool may not be helpful or easy to use for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Communication lymphoma neoplasm plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LYMPHOMA MULTIPLE MYELOMA

Contacts and locations

Locations

Washington University School of Medicine
RECRUITING

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.